米国の人工呼吸・麻酔用マスク市場規模、シェア、動向分析レポート：マスクタイプ別、用途別、セグメント別予測、2025～2030年

米国の人工呼吸・麻酔用マスク市場規模＆動向

米国の人工呼吸・麻酔用マスク市場規模は2024年に5億5,270万米ドルと推定され、2025～2030年にかけてCAGR 4.7%で成長すると予測されています。

この成長は、呼吸器疾患の発生率の上昇、技術開発、手術件数の増加、人口増加、特に高齢者の増加、COVID-19パンデミックの影響、ヘルスケア支出の増加、施策支援に起因しています。

COPD、喘息、肺炎などの慢性呼吸器疾患の有病率の上昇が市場の成長を促進します。2024年6月のCDC報告によると、米国の成人約600万人がCOPDに罹患しており、米国の死因上位10の1つであることから、ヘルスケアプロバイダやメーカーが呼吸ケアソリューションに投資する大きな機会となっています。また、成人や小児の肺疾患に対する長期的な在宅ケアや緊急治療の需要が増加していることも、市場需要に寄与しています。

技術の開発により、より使いやすく効率的な人工呼吸・麻酔用マスクが開発されています。ディスポーザブル用の統合モニタリングシステム、患者の快適性を高めるためのマスクデザインの改良、安全機能の強化などの特徴が、ヘルスケアプロバイダをこれらの製品に惹きつけています。さらに、高品質の呼吸ケアソリューションに対する需要が高まるにつれ、メーカーは医療従事者の進化するニーズに応える革新的な製品を生み出すために研究開発に投資しています。患者の快適性、安全性、有効性に焦点を当てた人工呼吸・麻酔用マスク市場は、今後数年間で大きく成長する見込みです。

COVID-19パンデミックは米国の人工呼吸・麻酔用マスク市場に大きな影響を与え、重篤な呼吸器合併症の多発による呼吸補助装置の需要急増を促しました。病院や救急部は人工呼吸器やマスクを含む関連消耗品の深刻な不足に直面し、急速な生産規模の拡大とFDAによる緊急使用認可を促しました。この危機は、交差汚染のリスクを減らすために使い捨てマスクの採用を加速させ、非侵襲的呼吸技術の革新に拍車をかけた。さらに、サプライチェーンの混乱と原料の不足が脆弱性を露呈し、パンデミック後の国内生産への取り組みと備蓄戦略の強化につながりました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• ビジネス環境分析
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 価格分析
  • COVID-19の影響

第4章 米国の人工呼吸・麻酔用マスク市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 米国の人工呼吸・麻酔用マスク市場：タイプ変動分析、100万米ドル、2024年と2030年
• 使い捨てマスク
• 再利用型マスク

第5章 米国の人工呼吸・麻酔用マスク市場：用途別、推定・動向分析

• セグメントダッシュボード
• 米国の人工呼吸・麻酔用マスク市場：用途変動分析、2024年と2030年
• 手術室
• 集中治療室
• 救急室
• 在宅医療
• ASC

第6章 競合情勢

• 参加者概要
• 2024年の企業市場ポジション/シェア分析
• 企業分類
• 企業プロファイル/上場企業
  • Medtronic
  • BD（Becton, Dickinson and Company）
  • ResMed
  • Vyaire Medical, Inc.
  • Dragerwerk AG & Co. KGaA
  • Koninklijke Philips NV
  • Nihon Kohden Corporation
  • Hamilton Medical
  • IBM
  • Ambu A/S
  • Cardinal Health

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. artificial ventilation and anesthesia masks market, Type, 2018 - 2030 (USD Million)
• Table 4 U.S. artificial ventilation and anesthesia masks market, by Application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Market segmentation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot
• Fig. 10 Competitive landscape snapshot
• Fig. 11 Market trends & outlook
• Fig. 12 Market driver relevance analysis (current & future impact)
• Fig. 13 Market restraint relevance analysis (current & future impact)
• Fig. 14 PESTLE analysis
• Fig. 15 Porter's five forces analysis
• Fig. 16 U.S. artificial ventilation and anesthesia masks market Type Outlook: Key Takeaways
• Fig. 17 U.S. artificial ventilation and anesthesia masks market: type movement analysis, 2018 & 2030
• Fig. 18 Disposable masks market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 19 Reusable masks market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 20 U.S. artificial ventilation and anesthesia masks market application outlook: Key takeaways
• Fig. 21 U.S. artificial ventilation and anesthesia masks market: application movement analysis, 2018 & 2030 (USD Million)
• Fig. 22 Operating Rooms market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 23 ICU market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 24 Emergency rooms market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 25 Home care market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 26 ASCs market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 27 Market Participant Categorization
• Fig. 28 Strategy mapping
• Fig. 29 Company market position analysis

U.S. Artificial Ventilation And Anesthesia Masks Market Size & Trends:

The U.S. artificial ventilation and anesthesia masks market size was estimated at USD 552.7 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth, especially of the geriatric people, effects of the covid-19 pandemic, increased healthcare spending, and support in the policies.

The rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. According to the CDC report of June 2024, around 6 million adults in the U.S. have COPD, and it is one of the top 10 causes of death in the U.S., presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.

Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia masks market is poised for significant growth in the coming years.

The COVID-19 pandemic greatly impacted the U.S. artificial ventilation and anesthesia masks market, driving a surge in demand for respiratory support equipment due to the high incidence of severe respiratory complications. Hospitals and emergency departments faced acute shortages of ventilators and associated consumables, including masks, prompting rapid production scale-ups and emergency use authorizations by the FDA. The crisis accelerated the adoption of single-use and disposable masks to reduce cross-contamination risks and spurred innovations in non-invasive ventilation technologies. Additionally, supply chain disruptions and raw material shortages exposed vulnerabilities, leading to increased domestic manufacturing initiatives and stockpiling strategies post-pandemic.

U.S. Artificial Ventilation And Anesthesia Masks Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask type and application:

• Mask Type Outlook (Revenue, USD Million, 2018 - 2030)
• Disposable Masks
• Reusable Masks
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Operating Rooms
• ICU
• Emergency Rooms
• Home Care
• ASCs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of surgical procedures across hospitals and ambulatory centers
    • 3.2.1.2. Growing prevalence of respiratory disorders
    • 3.2.1.3. Technological advancements in mask materials, ergonomics, and integration with monitoring systems are enhancing product safety and comfort.
    • 3.2.1.4. Increased focus on patient safety and infection control
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of alternative solutions
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Impact of COVID 19

Chapter 4. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Movement Analysis, USD Million, 2024 & 2030
• 4.3. Disposable Masks
  • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Reusable Masks
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2024 & 2030
• 5.3. Operating Rooms
  • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. ICU
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Emergency Rooms
  • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Homecare
  • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. ASCs
  • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position/Share Analysis, 2024
• 6.3. Company Categorization
• 6.4. Company Profiles/Listing
  • 6.4.1. Medtronic
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. BD (Becton, Dickinson and Company)
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. ResMed
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Vyaire Medical, Inc.
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Dragerwerk AG & Co. KGaA
    • 6.4.5.1. Overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Koninklijke Philips N.V.
    • 6.4.6.1. Overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. Nihon Kohden Corporation
    • 6.4.7.1. Overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Hamilton Medical
    • 6.4.8.1. Overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. IBM
    • 6.4.9.1. Overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. Ambu A/S
    • 6.4.10.1. Overview
    • 6.4.10.2. Financial performance
    • 6.4.10.3. Product benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Cardinal Health
    • 6.4.11.1. Overview
    • 6.4.11.2. Financial performance
    • 6.4.11.3. Product benchmarking
    • 6.4.11.4. Strategic initiatives